A subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more ...
DNA mismatch repair (MMR) is a fundamental pathway that maintains genomic integrity by recognising and correcting errors introduced during DNA replication and recombination. In prokaryotes, the ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Phase 3 KEYNOTE‑C93 trial evaluating KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, met its primary ...
Management of Diffuse Large B-Cell Lymphoma: Are We Getting Smarter? In the article that accompanies this editorial, Chung et al 16 describe a functional assay, Low-pass Genomic Instability ...
Antitumor activity of CTO given orally in combination with temozolomide in the SC251 human glioblastoma model. Background: Microsatellite instability (MSI), the result of defective DNA mismatch repair ...
Dostarlimab treatment led to complete clinical responses in 82% of patients with dMMR tumors, avoiding surgery for most. Recurrence-free survival at two years was 92%, with a median follow-up of 20 ...
A retrospective study found that patients with mismatch repair (MMR)-deficient advanced or recurrent endometrial cancer had numerically longer overall survival (OS) than those with MMR-proficient ...
A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...
A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...
Prime editing is an improved variant of the CRISPR/Cas system that can introduce alterations in DNA with exquisite precision. But the method is complex and inefficient. A research group has now been ...
CAMBRIDGE, Mass. & BEIJING & BASEL, Switzerland--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results